Survey on the usefulness of the video laryngoscope i-view

JRCT ID: jRCTs062220047

Registered date:08/08/2022

Basic Information

• Recruitment status: Recruiting
• Health condition(s) or Problem(s) studied: Tracheal intubation with general anesthesia
• Date of first enrollment: 08/08/2022
• Target sample size: 100
• Study type: Interventional

Intervention(s)

The subjects are dental and oral surgery cases scheduled for tracheal intubation under general anest
hesia.Anesthesia is guided and tracheal intubationis performed after falling asleep.
At this time, the glottis is confirmed by operating the larynx with a laryngoscope, and the tracheal tu
be is intubated.The following items are evaluated after intubation.After evaluation, the patient under
goes scheduled surgery.Such tracheal intubation using a laryngoscope is within the scope of normal
procedures, and it is expected that the evaluation will have very little effect on anesthesia managem
ent and anesthesia maintenance.
Evaluation item
(Evaluator) Measurement of time required for insertion
(Enforcer) Evaluate the following items after intubation
Presence or absence of lip / tooth damage and tooth dislocation when the larynx is deployed

Outcome(s)

• Primary Outcome: Time required for endotracheal intubation

Secondary Outcome

Items related to endotracheal intubation by the int
ubator
Laryngeal field of view
Intubation success rate
Number of enforcement
Presence or absence of support operation
Difficulty of operability

Key inclusion & exclusion criteria

• Age minimum: >= 16age old
• Age maximum: Not applicable
• Gender: Both

Include criteria

1.Patients scheduled for endotracheal intubation under general anesthesia
2.Patients of the American Society of Anesthesia (ASA) Physical Statas (PS) I and II
3.Patients 16 years and older

Exclude criteria

1. Patients scheduled for emergency surgery
2. Patients with ASA PS III, IV, V
3. Obese patients (body mass index: BMI> 30)
4. Patients with cognitive dysfunction

Related Information

• Primary Sponsor: KAWAHITO Shinji
• Source(s) of Monetary Support: Japan Medicalnext Co.,Ltd.